Phosphopantetheine compounds alone or in combination with HMG-COA redectase inhibitors for lowering serum cholesterol and serum triglycerides

摘要

The invention relates to the use of a phosphopantane compound alone or in combination with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Preferred medical use refers to the treatment or prevention of dyslipidemia.